English

PHARMACEUTICAL FORMULATIONS INC

EDGAR

Quarterly report (10-Q) · filed 2006-02-23

52 filing records in this dataset, filed from 1995-05-11 to 2006-02-23. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.96 million USD

2005-07-02 · USD

Exact inputs and evidence

Revenue: 1964000 USD Source

Operating margin

-27.14%

2005-07-02 · %

Exact inputs and evidence

Operating Income: -533000 USD Source
Revenue: 1964000 USD Source

Cash and cash equivalents: 1 thousand USD 2005-04-02 Source
Exact value

1000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2006-02-23.

Financial data available through: 2005-01-01.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2002-12-28
Operating income: 11 of 11 periods available· newest 2002-12-28
Net income: 11 of 11 periods available· newest 2005-01-01
Operating cash flow: 11 of 11 periods available· newest 2005-01-01
capital expenditure: No compatible figures in this window
Total assets: 3 of 11 periods available· newest 2004-01-03
liabilities: No compatible figures in this window
Current assets: 7 of 11 periods available· newest 2005-01-01
Current liabilities: 7 of 11 periods available· newest 2005-01-01
Cash and cash equivalents: 7 of 11 periods available· newest 2005-01-01
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 6.05 million

Prior period

−USD 1.84 million

2003-01-04 – 2004-01-03
Current period

−USD 7.89 million

2004-01-02 – 2005-01-01

Exact inputs and evidence

-7889000 − -1841000 = -6048000 USD

-1841000 USD · 2003-01-04 – 2004-01-03
Inspect prior input Prior source
-7889000 USD · 2004-01-02 – 2005-01-01
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PHARMACEUTICAL FORMULATIONS INC · 2005-01-01 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Year-over-year change in Net income: -6048000 USD Concept: fundies:NetIncome Period: 2004-01-02 to 2005-01-01 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -7889000 USD (2004-01-02 to 2005-01-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-05-000317.txt#3899 Input fundies:NetIncome: -1841000 USD (2003-01-04 to 2004-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-05-000317.txt#3899
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-68.9%

Prior period

USD 6.6 million

2003-01-04 – 2004-01-03
Current period

USD 2.05 million

2004-01-02 – 2005-01-01

Exact inputs and evidence

2052000 − 6597000 = -4545000 USD

6597000 USD · 2003-01-04 – 2004-01-03
Inspect prior input Prior source
2052000 USD · 2004-01-02 – 2005-01-01
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PHARMACEUTICAL FORMULATIONS INC · 2005-01-01 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Year-over-year change in Operating cash flow: -4545000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-02 to 2005-01-01 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 2052000 USD (2004-01-02 to 2005-01-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-05-000317.txt#3919 Input fundies:OperatingCashFlow: 6597000 USD (2003-01-04 to 2004-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-05-000317.txt#3919
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2002 2001-12-29 – 2002-12-28

Revenue USD 52.46 million 100% of revenue
Cost of revenue USD 46.51 million 89% of revenue
Operating expenses USD 10 million 19% of revenue
Operating income −USD 4.05 million −7.7% of revenue
Tax, interest and other Derived USD 2.84 million 5.4% of revenue
Net income −USD 6.89 million −13% of revenue

Cash

Operating cash flow −USD 7.57 million −14% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2000 Net loss: net income was −10% of revenue.
2000 Net loss: net income was −10% of revenue.
2001 Operating loss: operating costs were 119% of revenue.
2001 Operating loss: operating costs were 119% of revenue.
2001 Operating loss: operating costs were 119% of revenue.
2002 Operating loss: operating costs were 110% of revenue.
2002 Operating loss: operating costs were 108% of revenue.
2002 Operating loss: operating costs were 108% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2000 1999-07-02 – 2000-07-01	76579000	75819000 Derived	760000	8678000 Derived	-7918000	Unavailable	Source 1999-07-02 – 2000-07-01: 76579000 USD Inspect Revenue Open source 1999-07-02 – 2000-07-01: 760000 USD Inspect Operating Income Open source 1999-07-02 – 2000-07-01: -7918000 USD Inspect Net Income Open source 1999-07-02 – 2000-07-01: 4950000 USD Inspect Operating Cash Flow Open source
2000 1999-12-29 – 2000-12-28	76579000	75819000 Derived	760000	8678000 Derived	-7918000	Unavailable	Source 1999-12-29 – 2000-12-28: 76579000 USD Inspect Revenue Open source 1999-12-29 – 2000-12-28: 760000 USD Inspect Operating Income Open source 1999-12-29 – 2000-12-28: -7918000 USD Inspect Net Income Open source 1999-12-29 – 2000-12-28: 4950000 USD Inspect Operating Cash Flow Open source
2001 2000-01-04 – 2001-01-03	49157000	58291000 Derived	-9134000	-7293000 Derived	-1841000	Unavailable	Source 2000-01-04 – 2001-01-03: 49157000 USD Inspect Revenue Open source 2000-01-04 – 2001-01-03: -9134000 USD Inspect Operating Income Open source 2000-01-04 – 2001-01-03: -1841000 USD Inspect Net Income Open source 2000-01-04 – 2001-01-03: 6597000 USD Inspect Operating Cash Flow Open source
2001 2000-07-01 – 2001-06-30	49157000	58291000 Derived	-9134000	5458000 Derived	-14592000	Unavailable	Source 2000-07-01 – 2001-06-30: 49157000 USD Inspect Revenue Open source 2000-07-01 – 2001-06-30: -9134000 USD Inspect Operating Income Open source 2000-07-01 – 2001-06-30: -14592000 USD Inspect Net Income Open source 2000-07-01 – 2001-06-30: -15110000 USD Inspect Operating Cash Flow Open source
2001 2000-12-29 – 2001-12-28	49157000	58291000 Derived	-9134000	5458000 Derived	-14592000	Unavailable	Source 2000-12-29 – 2001-12-28: 49157000 USD Inspect Revenue Open source 2000-12-29 – 2001-12-28: -9134000 USD Inspect Operating Income Open source 2000-12-29 – 2001-12-28: -14592000 USD Inspect Net Income Open source 2000-12-29 – 2001-12-28: -15110000 USD Inspect Operating Cash Flow Open source
2002 2001-01-04 – 2002-01-03	26125000	28758000 Derived	-2633000	2313000 Derived	-4946000	Unavailable	Source 2001-01-04 – 2002-01-03: 26125000 USD Inspect Revenue Open source 2001-01-04 – 2002-01-03: -2633000 USD Inspect Operating Income Open source 2001-01-04 – 2002-01-03: -4946000 USD Inspect Net Income Open source 2001-01-04 – 2002-01-03: 2535000 USD Inspect Operating Cash Flow Open source
2002 2001-06-30 – 2002-06-29	52457000	56507000 Derived	-4050000	2838000 Derived	-6888000	Unavailable	Source 2001-06-30 – 2002-06-29: 52457000 USD Inspect Revenue Open source 2001-06-30 – 2002-06-29: -4050000 USD Inspect Operating Income Open source 2001-06-30 – 2002-06-29: -6888000 USD Inspect Net Income Open source 2001-06-30 – 2002-06-29: -7565000 USD Inspect Operating Cash Flow Open source
2002 2001-12-29 – 2002-12-28	52457000	56507000 Derived	-4050000	2838000 Derived	-6888000	Unavailable	Source 2001-12-29 – 2002-12-28: 52457000 USD Inspect Revenue Open source 2001-12-29 – 2002-12-28: -4050000 USD Inspect Operating Income Open source 2001-12-29 – 2002-12-28: -6888000 USD Inspect Net Income Open source 2001-12-29 – 2002-12-28: -7565000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 52.5M 2002

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-06-30	Revenue	80829000	Revenue: 80829000 Open source
19991999-07-03	Revenue	82174000	Revenue: 82174000 Open source
20002000-07-01	Revenue	76579000	Revenue: 76579000 Open source
20002000-12-28	Revenue	76579000	Revenue: 76579000 Open source
20012001-01-03	Revenue	49157000	Revenue: 49157000 Open source
20012001-06-30	Revenue	49157000	Revenue: 49157000 Open source
20012001-12-28	Revenue	49157000	Revenue: 49157000 Open source
20022002-01-03	Revenue	26125000	Revenue: 26125000 Open source
20022002-06-29	Revenue	52457000	Revenue: 52457000 Open source
20022002-12-28	Revenue	52457000	Revenue: 52457000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

6.7% 2002

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-06-30	Year over year	13.7%	Revenue: 80829000 Open source Revenue: 71117000 Open source
19991999-07-03	Year over year	1.7%	Revenue: 82174000 Open source Revenue: 80829000 Open source
20002000-07-01	Year over year	-6.8%	Revenue: 76579000 Open source Revenue: 82174000 Open source
20002000-12-28	Year over year	No prior comparable period	Revenue: 76579000 Open source
20012001-01-03	Year over year	No prior comparable period	Revenue: 49157000 Open source
20012001-06-30	Year over year	-35.8%	Revenue: 49157000 Open source Revenue: 76579000 Open source
20012001-12-28	Year over year	-35.8%	Revenue: 49157000 Open source Revenue: 76579000 Open source
20022002-01-03	Year over year	-65.9%	Revenue: 26125000 Open source Revenue: 76579000 Open source
20022002-06-29	Year over year	6.7%	Revenue: 52457000 Open source Revenue: 49157000 Open source
20022002-12-28	Year over year	6.7%	Revenue: 52457000 Open source Revenue: 49157000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -7.7% 2002

Net margin -13.1% 2002

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-06-30	Operating margin	7.1%	Operating Income: 5731000 Open source Revenue: 80829000 Open source
19991999-07-03	Operating margin	-4.9%	Operating Income: -4010000 Open source Revenue: 82174000 Open source
20002000-07-01	Operating margin	1%	Operating Income: 760000 Open source Revenue: 76579000 Open source
20002000-12-28	Operating margin	1%	Operating Income: 760000 Open source Revenue: 76579000 Open source
20012001-01-03	Operating margin	-18.6%	Operating Income: -9134000 Open source Revenue: 49157000 Open source
20012001-06-30	Operating margin	-18.6%	Operating Income: -9134000 Open source Revenue: 49157000 Open source
20012001-12-28	Operating margin	-18.6%	Operating Income: -9134000 Open source Revenue: 49157000 Open source
20022002-01-03	Operating margin	-10.1%	Operating Income: -2633000 Open source Revenue: 26125000 Open source
20022002-06-29	Operating margin	-7.7%	Operating Income: -4050000 Open source Revenue: 52457000 Open source
20022002-12-28	Operating margin	-7.7%	Operating Income: -4050000 Open source Revenue: 52457000 Open source
1998-06-30	Net margin	Not reported	Revenue: 80829000 Open source
19991999-07-03	Net margin	-8%	Net Income: -6565000 Open source Revenue: 82174000 Open source
20002000-07-01	Net margin	-10.3%	Net Income: -7918000 Open source Revenue: 76579000 Open source
20002000-12-28	Net margin	-10.3%	Net Income: -7918000 Open source Revenue: 76579000 Open source
20012001-01-03	Net margin	-3.7%	Net Income: -1841000 Open source Revenue: 49157000 Open source
20012001-06-30	Net margin	-29.7%	Net Income: -14592000 Open source Revenue: 49157000 Open source
20012001-12-28	Net margin	-29.7%	Net Income: -14592000 Open source Revenue: 49157000 Open source
20022002-01-03	Net margin	-18.9%	Net Income: -4946000 Open source Revenue: 26125000 Open source
20022002-06-29	Net margin	-13.1%	Net Income: -6888000 Open source Revenue: 52457000 Open source
20022002-12-28	Net margin	-13.1%	Net Income: -6888000 Open source Revenue: 52457000 Open source
19981998-06-30	Free cash flow margin	Not reported	Revenue: 80829000 Open source
19991999-07-03	Free cash flow margin	Not reported	Revenue: 82174000 Open source
20002000-07-01	Free cash flow margin	Not reported	Revenue: 76579000 Open source Operating Cash Flow: 4950000 Open source
20002000-12-28	Free cash flow margin	Not reported	Revenue: 76579000 Open source Operating Cash Flow: 4950000 Open source
20012001-01-03	Free cash flow margin	Not reported	Revenue: 49157000 Open source Operating Cash Flow: 6597000 Open source
20012001-06-30	Free cash flow margin	Not reported	Revenue: 49157000 Open source Operating Cash Flow: -15110000 Open source
20012001-12-28	Free cash flow margin	Not reported	Revenue: 49157000 Open source Operating Cash Flow: -15110000 Open source
20022002-01-03	Free cash flow margin	Not reported	Revenue: 26125000 Open source Operating Cash Flow: 2535000 Open source
20022002-06-29	Free cash flow margin	Not reported	Revenue: 52457000 Open source Operating Cash Flow: -7565000 Open source
20022002-12-28	Free cash flow margin	Not reported	Revenue: 52457000 Open source Operating Cash Flow: -7565000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -7.6M 2002

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-06-30	Operating cash flow	Not reported	No source recorded
19991999-07-03	Operating cash flow	Not reported	No source recorded
20002000-07-01	Operating cash flow	4950000	Operating Cash Flow: 4950000 Open source
20002000-12-28	Operating cash flow	4950000	Operating Cash Flow: 4950000 Open source
20012001-01-03	Operating cash flow	6597000	Operating Cash Flow: 6597000 Open source
20012001-06-30	Operating cash flow	-15110000	Operating Cash Flow: -15110000 Open source
20012001-12-28	Operating cash flow	-15110000	Operating Cash Flow: -15110000 Open source
20022002-01-03	Operating cash flow	2535000	Operating Cash Flow: 2535000 Open source
20022002-06-29	Operating cash flow	-7565000	Operating Cash Flow: -7565000 Open source
20022002-12-28	Operating cash flow	-7565000	Operating Cash Flow: -7565000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-06-30	Free cash flow	Unavailable	No source recorded
19991999-07-03	Free cash flow	Unavailable	No source recorded
20002000-07-01	Free cash flow	Unavailable	Operating Cash Flow: 4950000 Open source
20002000-12-28	Free cash flow	Unavailable	Operating Cash Flow: 4950000 Open source
20012001-01-03	Free cash flow	Unavailable	Operating Cash Flow: 6597000 Open source
20012001-06-30	Free cash flow	Unavailable	Operating Cash Flow: -15110000 Open source
20012001-12-28	Free cash flow	Unavailable	Operating Cash Flow: -15110000 Open source
20022002-01-03	Free cash flow	Unavailable	Operating Cash Flow: 2535000 Open source
20022002-06-29	Free cash flow	Unavailable	Operating Cash Flow: -7565000 Open source
20022002-12-28	Free cash flow	Unavailable	Operating Cash Flow: -7565000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-06-30	Liabilities / assets	Not reported	No source recorded
1999-07-03	Liabilities / assets	Not reported	Total Assets: 59653000 Open source
2000-07-01	Liabilities / assets	Not reported	Total Assets: 44565000 Open source
2000-12-28	Liabilities / assets	Not reported	No source recorded
2001-01-03	Liabilities / assets	Not reported	No source recorded
2001-06-30	Liabilities / assets	Not reported	No source recorded
2001-12-28	Liabilities / assets	Not reported	No source recorded
2002-01-03	Liabilities / assets	Not reported	No source recorded
2002-06-29	Liabilities / assets	Not reported	No source recorded
2002-12-28	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

1.03× 2002

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1998-06-30	Current assets / current liabilities	Not reported	No source recorded
19991999-07-03	Current assets / current liabilities	1.28×	Current Assets: 38003000 Open source Current Liabilities: 29615000 Open source
20002000-07-01	Current assets / current liabilities	1.1×	Current Assets: 27779000 Open source Current Liabilities: 25214000 Open source
2000-12-28	Current assets / current liabilities	Not reported	No source recorded
2001-01-03	Current assets / current liabilities	Not reported	No source recorded
20012001-06-30	Current assets / current liabilities	0.52×	Current Assets: 19174000 Open source Current Liabilities: 36944000 Open source
2001-12-28	Current assets / current liabilities	Not reported	No source recorded
2002-01-03	Current assets / current liabilities	Not reported	No source recorded
20022002-06-29	Current assets / current liabilities	1.02×	Current Assets: 21883000 Open source Current Liabilities: 21510000 Open source
20022002-12-28	Current assets / current liabilities	1.03×	Current Assets: 24029000 Open source Current Liabilities: 23234000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 1999-07-02 – 2000-07-01	−USD 7.92 million Exact value Exact value: -7918000 USD 1999-07-02 – 2000-07-01: -7918000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACEUTICAL FORMULATIONS INC · 2000-07-01 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Net Income: -7918000 USD Concept: fundies:NetIncome Period: 1999-07-02 to 2000-07-01 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3ANetIncome&period=2000-07-01&surface=latest&period_type=duration&start=1999-07-02&unit=USD&dimensions= Input fundies:NetIncome: -7918000 USD (1999-07-02 to 2000-07-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-02-000353.txt#3591 The citation records this snapshot. The page link may show a newer release later.	USD 4.95 million Exact value Exact value: 4950000 USD 1999-07-02 – 2000-07-01: 4950000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACEUTICAL FORMULATIONS INC · 2000-07-01 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Operating Cash Flow: 4950000 USD Concept: fundies:OperatingCashFlow Period: 1999-07-02 to 2000-07-01 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3AOperatingCashFlow&period=2000-07-01&surface=latest&period_type=duration&start=1999-07-02&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4950000 USD (1999-07-02 to 2000-07-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-02-000353.txt#3609 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2000 1999-12-29 – 2000-12-28	−USD 7.92 million Exact value Exact value: -7918000 USD 1999-12-29 – 2000-12-28: -7918000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACEUTICAL FORMULATIONS INC · 2000-12-28 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Net Income: -7918000 USD Concept: fundies:NetIncome Period: 1999-12-29 to 2000-12-28 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3ANetIncome&period=2000-12-28&surface=latest&period_type=duration&start=1999-12-29&unit=USD&dimensions= Input fundies:NetIncome: -7918000 USD (1999-12-29 to 2000-12-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-03-000154.txt#3988 The citation records this snapshot. The page link may show a newer release later.	USD 4.95 million Exact value Exact value: 4950000 USD 1999-12-29 – 2000-12-28: 4950000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACEUTICAL FORMULATIONS INC · 2000-12-28 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Operating Cash Flow: 4950000 USD Concept: fundies:OperatingCashFlow Period: 1999-12-29 to 2000-12-28 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-28&surface=latest&period_type=duration&start=1999-12-29&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4950000 USD (1999-12-29 to 2000-12-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-03-000154.txt#4015 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2000-01-04 – 2001-01-03	−USD 1.84 million Exact value Exact value: -1841000 USD 2000-01-04 – 2001-01-03: -1841000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACEUTICAL FORMULATIONS INC · 2001-01-03 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Net Income: -1841000 USD Concept: fundies:NetIncome Period: 2000-01-04 to 2001-01-03 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3ANetIncome&period=2001-01-03&surface=latest&period_type=duration&start=2000-01-04&unit=USD&dimensions= Input fundies:NetIncome: -1841000 USD (2000-01-04 to 2001-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-04-000246.txt#4140 The citation records this snapshot. The page link may show a newer release later.	USD 6.6 million Exact value Exact value: 6597000 USD 2000-01-04 – 2001-01-03: 6597000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACEUTICAL FORMULATIONS INC · 2001-01-03 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Operating Cash Flow: 6597000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-04 to 2001-01-03 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3AOperatingCashFlow&period=2001-01-03&surface=latest&period_type=duration&start=2000-01-04&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6597000 USD (2000-01-04 to 2001-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-04-000246.txt#4161 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2000-07-01 – 2001-06-30	−USD 14.59 million Exact value Exact value: -14592000 USD 2000-07-01 – 2001-06-30: -14592000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACEUTICAL FORMULATIONS INC · 2001-06-30 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Net Income: -14592000 USD Concept: fundies:NetIncome Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3ANetIncome&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:NetIncome: -14592000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-02-000353.txt#3591 The citation records this snapshot. The page link may show a newer release later.	−USD 15.11 million Exact value Exact value: -15110000 USD 2000-07-01 – 2001-06-30: -15110000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACEUTICAL FORMULATIONS INC · 2001-06-30 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Operating Cash Flow: -15110000 USD Concept: fundies:OperatingCashFlow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3AOperatingCashFlow&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15110000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-02-000353.txt#3609 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2000-12-29 – 2001-12-28	−USD 14.59 million Exact value Exact value: -14592000 USD 2000-12-29 – 2001-12-28: -14592000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACEUTICAL FORMULATIONS INC · 2001-12-28 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Net Income: -14592000 USD Concept: fundies:NetIncome Period: 2000-12-29 to 2001-12-28 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3ANetIncome&period=2001-12-28&surface=latest&period_type=duration&start=2000-12-29&unit=USD&dimensions= Input fundies:NetIncome: -14592000 USD (2000-12-29 to 2001-12-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-03-000154.txt#3988 The citation records this snapshot. The page link may show a newer release later.	−USD 15.11 million Exact value Exact value: -15110000 USD 2000-12-29 – 2001-12-28: -15110000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACEUTICAL FORMULATIONS INC · 2001-12-28 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Operating Cash Flow: -15110000 USD Concept: fundies:OperatingCashFlow Period: 2000-12-29 to 2001-12-28 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-28&surface=latest&period_type=duration&start=2000-12-29&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15110000 USD (2000-12-29 to 2001-12-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-03-000154.txt#4015 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2001-01-04 – 2002-01-03	−USD 4.95 million Exact value Exact value: -4946000 USD 2001-01-04 – 2002-01-03: -4946000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACEUTICAL FORMULATIONS INC · 2002-01-03 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Net Income: -4946000 USD Concept: fundies:NetIncome Period: 2001-01-04 to 2002-01-03 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3ANetIncome&period=2002-01-03&surface=latest&period_type=duration&start=2001-01-04&unit=USD&dimensions= Input fundies:NetIncome: -4946000 USD (2001-01-04 to 2002-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-04-000246.txt#4140 The citation records this snapshot. The page link may show a newer release later.	USD 2.54 million Exact value Exact value: 2535000 USD 2001-01-04 – 2002-01-03: 2535000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACEUTICAL FORMULATIONS INC · 2002-01-03 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Operating Cash Flow: 2535000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-04 to 2002-01-03 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3AOperatingCashFlow&period=2002-01-03&surface=latest&period_type=duration&start=2001-01-04&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2535000 USD (2001-01-04 to 2002-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-04-000246.txt#4161 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2001-06-30 – 2002-06-29	−USD 6.89 million Exact value Exact value: -6888000 USD 2001-06-30 – 2002-06-29: -6888000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACEUTICAL FORMULATIONS INC · 2002-06-29 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Net Income: -6888000 USD Concept: fundies:NetIncome Period: 2001-06-30 to 2002-06-29 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3ANetIncome&period=2002-06-29&surface=latest&period_type=duration&start=2001-06-30&unit=USD&dimensions= Input fundies:NetIncome: -6888000 USD (2001-06-30 to 2002-06-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-05-000317.txt#3899 The citation records this snapshot. The page link may show a newer release later.	−USD 7.57 million Exact value Exact value: -7565000 USD 2001-06-30 – 2002-06-29: -7565000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACEUTICAL FORMULATIONS INC · 2002-06-29 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Operating Cash Flow: -7565000 USD Concept: fundies:OperatingCashFlow Period: 2001-06-30 to 2002-06-29 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3AOperatingCashFlow&period=2002-06-29&surface=latest&period_type=duration&start=2001-06-30&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7565000 USD (2001-06-30 to 2002-06-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-05-000317.txt#3919 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2001-12-29 – 2002-12-28	−USD 6.89 million Exact value Exact value: -6888000 USD 2001-12-29 – 2002-12-28: -6888000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACEUTICAL FORMULATIONS INC · 2002-12-28 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Net Income: -6888000 USD Concept: fundies:NetIncome Period: 2001-12-29 to 2002-12-28 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3ANetIncome&period=2002-12-28&surface=latest&period_type=duration&start=2001-12-29&unit=USD&dimensions= Input fundies:NetIncome: -6888000 USD (2001-12-29 to 2002-12-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-03-000154.txt#3988 The citation records this snapshot. The page link may show a newer release later.	−USD 7.57 million Exact value Exact value: -7565000 USD 2001-12-29 – 2002-12-28: -7565000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACEUTICAL FORMULATIONS INC · 2002-12-28 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Operating Cash Flow: -7565000 USD Concept: fundies:OperatingCashFlow Period: 2001-12-29 to 2002-12-28 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-28&surface=latest&period_type=duration&start=2001-12-29&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7565000 USD (2001-12-29 to 2002-12-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-03-000154.txt#4015 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2003-01-04 – 2004-01-03	−USD 1.84 million Exact value Exact value: -1841000 USD 2003-01-04 – 2004-01-03: -1841000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACEUTICAL FORMULATIONS INC · 2004-01-03 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Net Income: -1841000 USD Concept: fundies:NetIncome Period: 2003-01-04 to 2004-01-03 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3ANetIncome&period=2004-01-03&surface=latest&period_type=duration&start=2003-01-04&unit=USD&dimensions= Input fundies:NetIncome: -1841000 USD (2003-01-04 to 2004-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-05-000317.txt#3899 The citation records this snapshot. The page link may show a newer release later.	USD 6.6 million Exact value Exact value: 6597000 USD 2003-01-04 – 2004-01-03: 6597000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACEUTICAL FORMULATIONS INC · 2004-01-03 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Operating Cash Flow: 6597000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-04 to 2004-01-03 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3AOperatingCashFlow&period=2004-01-03&surface=latest&period_type=duration&start=2003-01-04&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6597000 USD (2003-01-04 to 2004-01-03) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-05-000317.txt#3919 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2004-01-02 – 2005-01-01	−USD 7.89 million Exact value Exact value: -7889000 USD 2004-01-02 – 2005-01-01: -7889000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMACEUTICAL FORMULATIONS INC · 2005-01-01 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Net Income: -7889000 USD Concept: fundies:NetIncome Period: 2004-01-02 to 2005-01-01 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3ANetIncome&period=2005-01-01&surface=latest&period_type=duration&start=2004-01-02&unit=USD&dimensions= Input fundies:NetIncome: -7889000 USD (2004-01-02 to 2005-01-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-05-000317.txt#3899 The citation records this snapshot. The page link may show a newer release later.	USD 2.05 million Exact value Exact value: 2052000 USD 2004-01-02 – 2005-01-01: 2052000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMACEUTICAL FORMULATIONS INC · 2005-01-01 PHARMACEUTICAL FORMULATIONS INC (edgar:353827) Operating Cash Flow: 2052000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-02 to 2005-01-01 Values: Latest reported Published: 2026-11-02T11:42:51Z Snapshot: 9f33fafa92cbc60d66d2620c836ddf0d8caf1d7267b23ffbe1f66d9b46f7b7d6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/353827/explain?concept=fundies%3AOperatingCashFlow&period=2005-01-01&surface=latest&period_type=duration&start=2004-01-02&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2052000 USD (2004-01-02 to 2005-01-01) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/353827/0000899681-05-000317.txt#3919 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

52 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000353827, 353827, edgar:353827

PHARMACEUTICAL FORMULATIONS INC

Latest quarter

Revenue

Operating margin

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2002 2001-12-29 – 2002-12-28

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation